DHL Group erzielt Ergebniswachstum im zweiten Quartal 2025 - Konzernumsatz sinkt durch Wechselkurseffekte und ein geringeres Momentum der Handelsvolumen im zweiten Quartal um 3,9 Prozent auf 19,8 Milliarden Euro (Q2 2024: 20,6 Milliarden Euro) - EBIT ...
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...
New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today announced an ...
Fraunhofer-Institut für Produktionstechnologie IPT
LONGi Green Energy Technology Co., Ltd.
Petach Tikva, Israel (ots/PRNewswire) - ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential ...
LONGi Green Energy Technology Co., Ltd.
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Cyber-secure and energy-saving AI chip developed for decentralized use without the cloud A new AI chip developed at the Technical University of Munich (TUM) works without the cloud server or internet connections needed by existing chips. The AI Pro, designed by Prof Hussam Amrouch, is modelled on the human brain. Its innovative neuromorphic architecture enables it to perform calculations on the spot, ensuring full cyber security. ...
Heidelberg, Germany, Milan, Seville, Spain and Binyamina, Israel (ots/PRNewswire) - A European-led consortium comprising Heidelberg University Hospital (UKHD), the European Institute of Oncology (IEO), Virgen Macarena University Hospital, and OncoHost today announced that it has been awarded a €2.5 million grant ...
Vienna, Austria (ots) - Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a ...
DHL Group startet mit Umsatz- und Ergebniswachstum in das Jahr 2025 - Konzernumsatz hat um 2,8 % auf 20.809 Millionen Euro zugelegt (Q1 2024: 20.251 Millionen Euro) - EBIT um 4,5 % auf 1.370 Millionen Euro (Q1 2024: 1.311 Millionen Euro) gestiegen - ...
Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...
